Author:
Weber Franz,Anlauf Manfred
Publisher
Springer Berlin Heidelberg
Reference108 articles.
1. Anlauf M, Weber F (2015) Hemmstoffe des Renin-Angiotensin-Systems. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungs-Report, Bd. 2015. Springer, Berlin Heidelberg, S 267–309
2. Arzneiverordnung in der Praxis;Arzneimittelkommission der Deutschen Ärzteschaft,2004
3. Aygören-Pürsün E, Magerl M, Maetzel A, Maurer M (2018) Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis 13:73. https://doi.org/10.1186/s13023-018-0815-5
4. Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA, ACCOMPLISH Trial investigators (2010) Renal outcomes with diff erent fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 375:1173–1181
5. Bangalore S, Kumar S, Wetterslev J, Messerli FH (2011) Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials. BMJ 342:d2234